Amarin Corporation PLC
AMRN
View Detailed Chart
13.935USD
+0.335+2.46%
Market hours （ET）Quotes delayed by 15 min
289.82MMarket Cap
LossP/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
+2.46%
5 Days
-1.45%
1 Month
-14.93%
6 Months
+11.12%
Year to Date
+43.66%
1 Year
+51.47%
View Detailed Chart
TradingKey Stock Score of Amarin Corporation PLC
Currency: USD Updated: 2025-12-22Key Insights
Amarin Corporation PLC's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 125/404 in the Biotechnology & Medical Research industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 12.00.In the medium term, the stock price is expected to trend down.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Amarin Corporation PLC's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
2
analysts
Hold
Current Rating
12.000
Target Price
-19.57%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Amarin Corporation PLC Highlights
StrengthsRisks
Amarin Corporation PLC is a pharmaceutical company. The Company is focused on the commercialization and development of therapeutics to improve cardiovascular (CV), health and reduce CV risk. The Company operates through the development and commercialization of VASCEPA. Its lead product, Vascepa (icosapent ethyl) capsule is used as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. This indication for Vascepa, known as the MARINE indication, is based primarily on the results from the MARINE study of Vascepa in this approved patient population. The Company sells Vascepa principally to wholesalers, as well as selected regional wholesalers and specialty pharmacy providers, or collectively, its distributors, which in turn resell Vascepa to retail pharmacies for resale to patients and healthcare providers.
Overvalued
The company’s latest PE is -3.25, at a high 3-year percentile range.
Institutional Buying
The latest institutional holdings are 4.18M shares, increasing 0.10% quarter-over-quarter.
Held by PRFDX
Star Investor PRFDX holds 0.00 shares of this stock.
Amarin Corporation PLC News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Amarin Corporation PLC Info
Amarin Corporation PLC is a pharmaceutical company. The Company is focused on the commercialization and development of therapeutics to improve cardiovascular (CV), health and reduce CV risk. The Company operates through the development and commercialization of VASCEPA. Its lead product, Vascepa (icosapent ethyl) capsule is used as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. This indication for Vascepa, known as the MARINE indication, is based primarily on the results from the MARINE study of Vascepa in this approved patient population. The Company sells Vascepa principally to wholesalers, as well as selected regional wholesalers and specialty pharmacy providers, or collectively, its distributors, which in turn resell Vascepa to retail pharmacies for resale to patients and healthcare providers.
Ticker SymbolAMRN
CompanyAmarin Corporation PLC
CEOBerg (Aaron D)
Websitehttps://amarincorp.com/
FAQs
What is the current price of Amarin Corporation PLC (AMRN)?
The current price of Amarin Corporation PLC (AMRN) is 13.935.
What is the symbol of Amarin Corporation PLC?
The ticker symbol of Amarin Corporation PLC is AMRN.
What is the 52-week high of Amarin Corporation PLC?
The 52-week high of Amarin Corporation PLC is 20.900.
What is the 52-week low of Amarin Corporation PLC?
The 52-week low of Amarin Corporation PLC is 7.080.
What is the market capitalization of Amarin Corporation PLC?
The market capitalization of Amarin Corporation PLC is 289.82M.
What is the net income of Amarin Corporation PLC?
The net income of Amarin Corporation PLC is -82.18M.
Is Amarin Corporation PLC (AMRN) currently rated as Buy, Hold, or Sell?
According to analysts, Amarin Corporation PLC (AMRN) has an overall rating of Hold, with a price target of 12.000.
What is the Earnings Per Share (EPS TTM) of Amarin Corporation PLC (AMRN)?
The Earnings Per Share (EPS TTM) of Amarin Corporation PLC (AMRN) is -4.178.
Related Instruments
+0.10%
-0.54%
+0.94%
+0.95%
+1.98%
+0.04%
+0.49%
+9.13%
+1.89%
-0.18%
+0.89%
-0.20%
-0.59%
+0.51%
+0.67%
+0.45%
+0.58%
0.00%
-0.61%
-1.93%Popular Symbols
